As of Feb 24
| +0.0054 / +1.37%|
The 3 analysts offering 12-month price forecasts for Xtant Medical Holdings Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 2.00. The median estimate represents a +774.78% increase from the last price of 0.40.
The current consensus among 3 polled investment analysts is to Buy stock in Xtant Medical Holdings Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.